Eric Dane, known for his roles in Euphoria and Grey's Anatomy, reveals his diagnosis of ALS. While the degenerative disease poses challenges, Dane remains optimistic about continuing his career and requests privacy for his family.
Euphoria's Eric Dane Opens Up About ALS Diagnosis and Future Plans

Euphoria's Eric Dane Opens Up About ALS Diagnosis and Future Plans
Actor Eric Dane shares his ALS diagnosis, expressing gratitude for family support and eagerness to resume work on Euphoria.
Euphoria star Eric Dane has made a poignant announcement regarding his health, revealing that he has been diagnosed with amyotrophic lateral sclerosis (ALS), the most prevalent form of motor neuron disease (MND). In an interview with People, the 52-year-old actor expressed gratitude for the support of his family as they face this new challenge together.
Dane expressed his appreciation for being able to continue his work, stating, "I feel fortunate that I am able to continue working and am looking forward to returning to set of Euphoria next week." He emphasized the importance of family support during this difficult time and requested privacy for himself and his loved ones.
Best known for his role as Cal Jacobs, the father in HBO's acclaimed series Euphoria, Dane will soon return to filming as season three begins production on Monday. Initially gaining fame as Dr. Mark Sloan in Grey's Anatomy, he has also appeared in popular series such as Charmed and The Last Ship, in addition to films like Marley & Me and Burlesque.
Amyotrophic lateral sclerosis is a rare degenerative condition that leads to progressive muscle paralysis. Symptoms often begin with limb weakness and twitching, potentially followed by speech difficulties. ALS affects nerve cells in the brain and spinal cord, gradually diminishing patients' ability to move, speak, eat, and breathe without assistance. Currently, there is no known cure, with life expectancy post-diagnosis typically ranging from three to five years, though some individuals live longer. As technology and research continue to advance, the quest for better understanding and treatment remains crucial.